-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師總結如下： CF Industries第一季業績強勁，每股盈餘（EPS）為3.98美元，高於去年同期的1.85美元，也高於市場普遍預期的2.66美元；調整後EBITDA成長53%至9.83億美元，也高於市場普遍預期的7.74億美元。淨銷售額成長19%至19.9億美元，超過市場普遍預期的18.6億美元，這主要得益於各業務板塊強勁的定價策略抵銷了Yazoo City工廠停產造成的銷售下降。卓越的營運執行力（氨產能利用率高達99%）以及在全球氮肥市場受限的情況下所採取的策略定位，都為該投資標的提供了有力支撐。管理階層預計2026年全年氨總產量約950萬噸，亞祖城計畫預計要到2026年第四季末才能恢復生產。鑑於中東衝突導致50%-60%的區域產能受到影響，以及液化天然氣供應受限影響依賴進口的地區，我們預計全球供需平衡緊張的情況將持續。 CF的低碳舉措，包括與Blue Point的合資企業和亞祖城碳捕集與封存（CCS）項目，為長期價值創造提供了結構性優勢。
Related Articles
Australia
CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says
CVS Health (CVS) is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings "comfortably" beat expectations, driven by "strong" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: $87.01, Change: $+0.14, Percent Change: +0.17%
$CVS
Research
Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Trimble Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price to $86, from 85, on a forward P/E of 21x our 2027 EPS projection of $4.08, below historical averages. We increase our 2026 EPS projection to $3.59 from $3.52, and lift our 2027 EPS estimate to $4.08 from $4.06. TRMB reported solid Q1 beats with revenue of $939.9M, up 12% Y/Y, led by AECO at 14% organic revenue and ARR growth, Field Systems posting 12% growth, and Transportation & Logistics growing 7% despite freight market headwinds. ARR reached a record $2.435B, up 13% organically, reinforcing business model durability. Non-GAAP operating margin improved 230 bps to 25.9%, while non-GAAP gross margins expanded 180 bps to 71.0%, and we see continued margin expansion as its subscription revenues scale. We note steady execution in its core business, while building AI momentum through new products and partnerships with AI labs. Management reaffirmed its 2027 targets, supporting our positive view, though macro risks warrant monitoring.
$TRMB
Australia
Apollo Global Trades at Lower Discount Versus Peers, RBC Says
Apollo Global Management (APO) shares are trading in-line with historical average multiple and at a lower discount against its peers, RBC Capital Markets said in a Thursday note."We maintain our Sector Perform rating largely driven by relative valuation," the report said.The note said its Q1 performance was characterized by strong fee-related earnings growth, offset by weak spread-related earnings growth, driving a low adjusted net income per share growth.RBC raised its price target to $146 from $139 on rolling forward its valuation and higher estimates.Price: $127.33, Change: $-2.20, Percent Change: -1.70%
$APO